The expression levels of certain biomarkers, such as EGFR, HER2, mucin MUC1 and insulin-like growth factor-1 receptor (IGF1R), are reduced in healthy cells but elevated in tumor cells. This evidence concerns the gene ERBB2 and neoplasm.